117 related articles for article (PubMed ID: 2835158)
1. Expression of alpha-amylase in human lung cancers.
Tomita N; Matsuura N; Horii A; Emi M; Nishide T; Ogawa M; Mori T; Doi O; Matsubara K
Cancer Res; 1988 Jun; 48(11):3292-6. PubMed ID: 2835158
[TBL] [Abstract][Full Text] [Related]
2. Expression of alpha-amylase isozymes in human thyroid tissues.
Doi S; Tomita N; Higasiyama M; Yokouchi H; Horii A; Yasuda T; Kobayashi T; Takai S; Ogawa M; Mori T
Cancer Res; 1991 Jul; 51(13):3544-9. PubMed ID: 2054791
[TBL] [Abstract][Full Text] [Related]
3. alpha-Amylase in resectable lung cancer.
Lenler-Petersen P; Grove A; Brock A; Jelnes R
Eur Respir J; 1994 May; 7(5):941-5. PubMed ID: 8050552
[TBL] [Abstract][Full Text] [Related]
4. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff H; Saukkonen K; Anttila S; Karjalainen A; Vainio H; Ristimäki A
Cancer Res; 1998 Nov; 58(22):4997-5001. PubMed ID: 9823297
[TBL] [Abstract][Full Text] [Related]
6. Fine needle aspiration cytology of atypical carcinoid of the lung.
Frierson HF; Covell JL; Mills SE
Acta Cytol; 1987; 31(4):471-5. PubMed ID: 3037832
[TBL] [Abstract][Full Text] [Related]
7. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
Gilbert JA; Frederick LM; Ames MM
Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255
[TBL] [Abstract][Full Text] [Related]
8. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung.
Yokota J; Akiyama T; Fung YK; Benedict WF; Namba Y; Hanaoka M; Wada M; Terasaki T; Shimosato Y; Sugimura T
Oncogene; 1988 Oct; 3(4):471-5. PubMed ID: 2856251
[TBL] [Abstract][Full Text] [Related]
11. Amylase in lung carcinomas. An ultrastructural and immunohistochemical study of two adenocarcinomas, and a review of the literature.
Grove A
APMIS; 1994 Feb; 102(2):135-44. PubMed ID: 7513172
[TBL] [Abstract][Full Text] [Related]
12. Preferential transcription of a gene for alpha amylase in the carcinoid tumor of African rodent Mastomys natalensis.
Daa T; Sato T; Kashima K; Nakayama I; Yokoyama S; Takeno S; Noguchi T; Uchida Y
J Exp Clin Cancer Res; 2002 Mar; 21(1):131-6. PubMed ID: 12071519
[TBL] [Abstract][Full Text] [Related]
13. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K
Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
[TBL] [Abstract][Full Text] [Related]
15. Higher expression of topoisomerase II in lung cancers than normal lung tissues: different expression pattern from topoisomerase I.
Hasegawa T; Isobe K; Nakashima I; Shimokata K
Biochem Biophys Res Commun; 1993 Aug; 195(1):409-14. PubMed ID: 8395833
[TBL] [Abstract][Full Text] [Related]
16. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
17. Lung carcinoma metastatic to the ovary: a clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis.
Irving JA; Young RH
Am J Surg Pathol; 2005 Aug; 29(8):997-1006. PubMed ID: 16006793
[TBL] [Abstract][Full Text] [Related]
18. Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma.
Strazisar M; Mlakar V; Rott T; Glavac D
Cancer Invest; 2009 May; 27(4):407-16. PubMed ID: 19229701
[TBL] [Abstract][Full Text] [Related]
19. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis.
van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ
Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278
[TBL] [Abstract][Full Text] [Related]
20. Incidence of latent infection of Epstein-Barr virus in lung cancers--an analysis of EBER1 expression in lung cancers by in situ hybridization.
Kasai K; Sato Y; Kameya T; Inoue H; Yoshimura H; Kon S; Kikuchi K
J Pathol; 1994 Dec; 174(4):257-65. PubMed ID: 7884587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
